Another Duchenne clinical hold gets lifted, this time at Dyne Therapeutics

Clinical holds have hampered a host of trials testing treatments for Duchenne muscular dystrophy, but one biotech is getting the go-ahead to start its study five and a half months after the initial roadblock.